Letermovir Prophylaxis Demonstrates High Efficacy in Adult Cytomegalovirus (CMV) Seropositive Cord Blood Transplant (CBT) Recipients: A Comparison with Pre-Letermovir Era CBT Controls-Reference-Cited by-同舟云学术

Letermovir Prophylaxis Demonstrates High Efficacy in Adult Cytomegalovirus (CMV) Seropositive Cord Blood Transplant (CBT) Recipients: A Comparison with Pre-Letermovir Era CBT Controls

Published:2019-03 Issue:3 Volume:25 Page:S94-S95
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Lau Carmen,Politikos Ioannis,Maloy Molly A.,Naputo Kristine,Afuye Aishat,Devlin Sean M.,Bhatt Valkal,Giralt Sergio A.,Jakubowski Ann A.,Papadopoulos Esperanza B.,Perales Miguel-Angel,Shaffer Brian C.,Seo Susan K.,Papanicolaou Genovefa A.,Barker Juliet N.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of allele-level HLA matching on outcomes after double cord blood transplantation in adults with malignancies;Blood Advances;2023-07-03

2. The changing impact of cytomegalovirus among hematopoietic cell transplant recipients during the past decade: A single institutional cohort study;Transplant Infectious Disease;2022-04-08

3. Letermovir Prophylaxis Decreases Burden of Cytomegalovirus (CMV) in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant;Biology of Blood and Marrow Transplantation;2020-10

4. Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation;Bone Marrow Transplantation;2019-10-29

5. Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience;Transplant Infectious Disease;2019-10-21